2018 Annual Meeting | C110 - Neurologic Complications in Adults with Down Syndrome

Date Tuesday 04/24/18

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Elizabeth M. Berry-Kravis, MD, PhD, Andrea L. Gropman, MD, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should become familiar with the effects of aging on the individual with DS and how that impacts clinical features and care. Participants will also have an appreciation of the biological basis of such changes and recent advances and updates in clinical trials and their effects on this population.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Didactic, Interactive

Event Timeline
01:00 PM - 01:05 PM	Luncheon	Introduction Andrea L. Gropman, MD, FAAN
01:05 PM - 01:40 PM	Speaker	Neurological Aspects of Aging in Down Syndrome: From Mouse to Man Ira T. Lott, MD
01:40 PM - 02:15 PM	Speaker	Cognitive Stabilizaton in DS and Clinical Trials Update Andrea L. Gropman, MD, FAAN
02:15 PM - 02:50 PM	Speaker	Neuropsychiatric Complications in Adults with DS Ryan Uy, MD
02:50 PM - 03:00 PM	Q&A	Questions and Answers

Faculty Disclosures
Elizabeth M. Berry-Kravis, MD, PhD	The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Zevra. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren.
Andrea L. Gropman, MD, FAAN	Dr. Gropman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Change Health Care. Dr. Gropman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cyprium. Dr. Gropman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Gropman has received research support from National Institutes of Health. The institution of Dr. Gropman has received research support from O'Malley Family Foundation.
	No disclosure on file
Ryan Uy, MD	No disclosure on file
Ira T. Lott, MD	No disclosure on file

��ɫ��

��ɫ��